IL2RA and acute lymphoblastic leukemia: Survival analysis studies using the Kaplan–Meier curve revealed that B-ALL patients who showed CD25+/CD123+ coexpression had shorter OS as compared to the negative ones (p < 0.01) (Figure 1).